Fijnheer R - Search Results

1

Acute activation of the endothelium results in increased levels of active von Willebrand factor in hemolysis, elevated liver enzymes and low platelets (HELLP) syndrome.

Hulstein JJ, van Runnard Heimel PJ, Franx A, Lenting PJ, Bruinse HW, Silence K, de Groot PG, Fijnheer R. Hulstein JJ, et al. Among authors: fijnheer r. J Thromb Haemost. 2006 Dec;4(12):2569-75. doi: 10.1111/j.1538-7836.2006.02205.x. Epub 2006 Sep 12. J Thromb Haemost. 2006. PMID: 16968329 Free article.

2

Factor V Leiden, antiphospholipid antibodies and thrombosis in systemic lupus erythematosus.

Fijnheer R, Horbach DA, Donders RC, Vilé H, von Oort E, Nieuwenhuis HK, Gmelig-Meijling FH, de Groot PG, Derksen RH. Fijnheer R, et al. Thromb Haemost. 1996 Oct;76(4):514-7. Thromb Haemost. 1996. PMID: 8902988

3

Soluble P-selectin as parameter for platelet activation during storage.

Kostelijk EH, Fijnheer R, Nieuwenhuis HK, Gouwerok CW, de Korte D. Kostelijk EH, et al. Among authors: fijnheer r. Thromb Haemost. 1996 Dec;76(6):1086-9. Thromb Haemost. 1996. PMID: 8972035

4

The origin of P-selectin as a circulating plasma protein.

Fijnheer R, Frijns CJ, Korteweg J, Rommes H, Peters JH, Sixma JJ, Nieuwenhuis HK. Fijnheer R, et al. Thromb Haemost. 1997 Jun;77(6):1081-5. Thromb Haemost. 1997. PMID: 9241736

5

Homocysteine, methylenetetrahydrofolate reductase polymorphism, antiphospholipid antibodies, and thromboembolic events in systemic lupus erythematosus: a retrospective cohort study.

Fijnheer R, Roest M, Haas FJ, De Groot PG, Derksen RH. Fijnheer R, et al. J Rheumatol. 1998 Sep;25(9):1737-42. J Rheumatol. 1998. PMID: 9733454

6

von Willebrand factor proteolysis is deficient in classic, but not in bone marrow transplantation-associated, thrombotic thrombocytopenic purpura.

van der Plas RM, Schiphorst ME, Huizinga EG, Hené RJ, Verdonck LF, Sixma JJ, Fijnheer R. van der Plas RM, et al. Among authors: fijnheer r. Blood. 1999 Jun 1;93(11):3798-802. Blood. 1999. PMID: 10339486 Free article.

7

Elastase mediated fibrinolysis in acute promyelocytic leukemia.

Oudijk EJ, Nieuwenhuis HK, Bos R, Fijnheer R. Oudijk EJ, et al. Among authors: fijnheer r. Thromb Haemost. 2000 Jun;83(6):906-8. Thromb Haemost. 2000. PMID: 10896247

8

Cyclosporine is associated with endothelial dysfunction but not with platelet activation in renal transplantation.

Schrama YC, van Dam T, Fijnheer R, Hené RJ, de Groot P, Rabelink TJ. Schrama YC, et al. Among authors: fijnheer r. Neth J Med. 2001 Jul;59(1):6-15. doi: 10.1016/s0300-2977(01)00127-9. Neth J Med. 2001. PMID: 11438194

9

Lupus anticoagulant and history of thrombosis are not associated with persistent endothelial cell activation in systemic lupus erythematosus.

Frijns CJ, Derksen RH, De Groot PG, Algra A, Fijnheer R. Frijns CJ, et al. Among authors: fijnheer r. Clin Exp Immunol. 2001 Jul;125(1):149-54. doi: 10.1046/j.1365-2249.2001.01520.x. Clin Exp Immunol. 2001. PMID: 11472438 Free PMC article.

10

Semicarbazide-sensitive amine oxidase in pre-eclampsia: no relation with markers of endothelial cell activation.

Sikkema JM, Franx A, Fijnheer R, Nikkels PG, Bruinse HW, Boomsma F. Sikkema JM, et al. Among authors: fijnheer r. Clin Chim Acta. 2002 Oct;324(1-2):31-8. doi: 10.1016/s0009-8981(02)00215-2. Clin Chim Acta. 2002. PMID: 12204422

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

185 results

Search Page